Improved Pharmacokinetics of Sumatriptan With B reath P owered™ Nasal Delivery of Sumatriptan Powder
نویسندگان
چکیده
منابع مشابه
Improved Pharmacokinetics of Sumatriptan With Breath Powered™ Nasal Delivery of Sumatriptan Powder
OBJECTIVES The purpose of this study was to directly compare the pharmacokinetic (PK) profile of 22-mg sumatriptan powder delivered intranasally with a novel Breath Powered™ device (11 mg in each nostril) vs a 20-mg sumatriptan liquid nasal spray, a 100-mg oral tablet, and a 6-mg subcutaneous injection. BACKGROUND A prior PK study found that low doses of sumatriptan powder delivered intranasa...
متن کاملClinical implications for breath-powered powder sumatriptan intranasal treatment.
The acute treatment of migraine requires matching patient need to drug and formulation. In particular, nausea and vomiting, quick time to peak intensity, and the common gastroparesis of migraineurs, all call for a variety of non-oral formulations for treatment of attacks. A novel breath-powered powder sumatriptan intranasal treatment offers an improvement, at least in pharmacokinetics, over con...
متن کاملTreatment of acute migraine with subcutaneous sumatriptan.
Sumatriptan succinate, a 5-HT1D receptor agonist, constricts human cranial arteries. Two parallel-group trials for treatment of acute migraines were conducted in the United States. Adult patients were randomized and given either 6 mg of sumatriptan succinate subcutaneously (n = 734) or placebo (n = 370). At 1 hour, sumatriptan was significantly more effective than placebo in reducing moderate o...
متن کاملSumatriptan and venoconstriction.
The paper by MB Vincent et 31. in this issue represents a further piece of investigation on the mechanism of action of sumatriptan. It focuses on the efficacy of the drug in aborting cluster headache ( CHj attacks, a clinical condition for which sumatriptan is highly effective and now represents the treatment of choice. The authors have chosen porcine ophthalmic artery ( POAj for evaluating the...
متن کاملSumatriptan iontophoretic patch for migraine.
Sumatriptan delivered in an electric patch form applied to the skin was approved by the Federal Drug Administration (FDA) in 2013 for the acute treatment of migraine. About 25 years ago, sumatriptan was the first drug in the medication class of triptans to be approved for the treatment of migraine. Sumatriptan already comes in a tablet, injectable form, nasal spray, and in at least 14 countries...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Headache: The Journal of Head and Face Pain
سال: 2013
ISSN: 0017-8748,1526-4610
DOI: 10.1111/head.12167